Home Tags Diabetes: Type II

Tag: Diabetes: Type II

Team Care With Clinical Decision Support System Beneficial for T2DM Patients

Significantly greater decreases seen in HbA1c levels, LDL-C levels, and systolic BP for team-based care with versus without CDSS

Preexisting Type 2 Diabetes Tied to Later Stage of Cancer Diagnosis

Increased risk seen for nonscreenable cancers

Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk

Association between exposure to antihyperglycemic medications for type 2 diabetes and risk for developing multiple sclerosis differs according to age and sex

Low-Carbohydrate Diet Yields Greater Decrease in HbA1c

Reductions in HbA1c, fasting plasma glucose, body weight at six months greater with low-carbohydrate diet versus usual diet in individuals with elevated untreated HbA1c

Thiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk

Sulfonylurea monotherapy linked to increased risk for all-cause dementia compared with metformin monotherapy

Effects of Weight Loss Methods Examined by Baseline Body Weight

Unlike people with obesity, lean individuals may not experience health benefits with intentional weight loss

Certain Meds Not Cost-Effective for First-Line Therapy of T2DM

Compared with metformin, SGLT2 inhibitors, GLP-1 receptor agonists cost more for treatment in drug-naive patients with type 2 diabetes

Semaglutide Reduces 10-Year Risk for T2D in Obese Persons

Sustained treatment with semaglutide needed to maintain reduction in risk for type 2 diabetes

Metabolic Surgery Beats Medical, Lifestyle Interventions for T2D Remission

Additional benefits from surgery seen for diabetes-related comorbidities and weight loss

USPSTF: Evidence Lacking for Screening Children for Prediabetes, T2D

Evidence insufficient for assessing benefits and harms of screening for children and adolescents